In this issue of the journal, Blake and co-authors 1 have followed up on their previous description of a preoperative assessment tool for the detection of likely obstructive sleep apnoea (OSA) 2 and compared, in patients so identified, the effect of an opioid-sparing analgesia protocol with that of a standard patient-controlled morphine technique on the incidence of postoperative respiratory events, as measured by limited polysomnography using respiratory sensors only.
The utility of such preoperative screening tests has recently been scrutinised in a meta-analysis by Ramachandran and Josephs 3 , who questioned the accuracy of such tools and concluded that most would likely miss a significant proportion of patients with OSA. Examination of the prediction system devised by Blake et al 2 suggests it is no different, their control (low risk) group having a mean of 14 obstructive events per hour during postoperative monitoring with some controls probably having studies consistent with moderate OSA using standard sleep medicine definitions. On the other hand, the group identified as being at risk appears to have included some patients who exhibited trivial postoperative airway obstruction, although it also appears the data were highly skewed. The minimum saturations were almost identical between the groups and the vast majority of desaturations were of a clinically trivial nature, falling only a few percent. The assessment tool is therefore unlikely to be either sensitive or specific enough to be clinically useful in the perioperative setting. Their finding that, on logistic regression, both the prediction tool, heavily dependent on body mass index, and age >50 years predicted postoperative event rates >15/hour, is entirely consistent with the known epidemiology of mild to moderate OSA. The clinical importance of a respiratory disturbance index of 15/hour in the perioperative context is doubtful.
Perhaps also not surprising is the report in this issue 1 that an opioid-sparing analgesic regimen, when used for patients identified as being at-risk on screening, failed to substantially reduce the number of postoperative respiratory events. This may have been, at least in part, because many patients in the opioid-sparing group required rescue morphine.
It is more likely that most of the patients in the study will have similar numbers and duration of events every night of their lives anyway, and even moderately sedative analgesia will not change that very much.
These studies highlight several problems: there is a lack of satisfactory evidence upon which to base risk stratification; there is considerable variability and confusion regarding syndrome definition and the applicability of those definitions in the perioperative setting; there are major practical obstacles, as we have seen, to both preoperative clinical screening and perioperative research; and management resources are usually inadequate to provide for the conservative approach recommended in most guidelines, even if we could identify patients at risk with adequate accuracy. Moreover, sleep-'disordered' breathing, of at least some degree, is so common, especially in older people, that we need to ask ourselves when it stops being normal and actually starts being a disorder. The perioperative implications of sleepdisordered breathing in paediatric and adult populations are also probably different, further complicating the issue. For the remainder of this article I will restrict my discussion to adults.
While there are case reports of disastrous outcomes, possibly associated with postoperative upper airway obstruction related to oversedation, and most of us are aware of a few likely sounding cases occurring around us from time to time, in reality the denominator must be very large, given the prevalence of OSA, and it is hard to be certain in most cases that an obstructive rather than central event was to blame. Closer examination of many of the reported cases, as well as the oft-cited earlier studies such as Catley's 4 , often reveal opioid analgesic techniques that would now be considered quite excessive if not outright dangerous. This calls into question the dire warnings often found in the literature and perhaps we should be concerned less about OSA per se and concentrate our efforts on more complex related problems like obesity hypoventilation syndrome 5 .
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Anaesthesia and Intensive Care, Vol. 37, No. 5, September 2009 often used in anaesthesia, if only by implication, to encompass a much broader spectrum of disorders including obesity hypoventilation syndrome. While there may be some overlap, the continued use of 'OSA' as a more or less generic term is impeding our ability to make sensible perioperative judgements. Secondly, the severity classifications used in adult sleep medicine, arbitrarily derived from the longterm risk of developing hypertension, bear little or no relevance in the perioperative setting and yet these classifications are widely used to determine perceived perioperative risk. Sleep-disordered breathing (obstructive and central) and obesity hypoventilation syndrome represent, across several dimensions, a continuum of disorders that also encompasses a further continuum of severity. Attempts to render patients into discrete perioperative risk categories are probably therefore not that helpful, especially if largely based on entirely arbitrary sleep medicine classifications.
A great deal of effort over the last decade has gone into the development of the aforementioned preoperative prediction models and clinical screening tools for OSA, ranging from simple questionnaires to morphometric and cephalometric studies. Ramachandran and Josephs 3 suggested that a combination of tools might detect a high proportion of severe sufferers but cost and time constraints, as well as patient enthusiasm, become prohibitive in most settings, with some 'OSA' questionnaires being almost as long as my hospital's entire pre-anaesthetic assessment questionnaire! Even the gold standard, polysomnography, suffers from a 'first night effect' leading to inaccuracy in diagnosis of milder cases particularly 3 . Attempts are also being made to develop portable devices capable of home recording polysomnographic subsets, but again finance is an issue, with Medicare rebates in Australia only available for monitored diagnostic sleep studies subsequently reported by registered sleep physicians. Whether such portable devices prove to be useful from a research perspective is yet to be determined.
Similar practicalities, however, still inhibit substantial perioperative research. Serious adverse postoperative events are relatively rare, despite the high prevalence of sleep-disordered breathing, and in order to determine the true nature of such events (obstructive or central and whether or not the patient was even asleep, for example), large numbers of subjects would need to be monitored with at least a substantial subset of polysomnography. This is not a minor undertaking.
On this background, a number of advisory bodies and individual institutions have developed perioperative management strategies for patients with known or suspected OSA 6 . Such guidelines tend to be overly cautious, potentially putting pressure on scarce and expensive high-dependency resources, delaying surgery and leading to inconvenience for patients. The extent to which this is justified is currently unknown, since all recommendations are based largely on consensus opinions and standard sleep medicine classifications in the absence of satisfactory evidence. The idea that an apnoea/hypopnoea index of 35 or 40/hour, which would usually lead to a diagnosis of 'severe' OSA, as opposed to one of say 28/hour (more likely to be called 'moderate'), might in some way make a substantial difference in the perioperative setting is, in my view, irrational, yet decisions about suitability for day surgery are often based on such arbitrary classifications.
Another interesting subject for consideration, and one that also possibly confounds our preconceptions, is the spectrum of effects attributed to intermittent hypoxia 7 . These range from potentially problematic (heightened opioid sensitivity) to potentially beneficial (hypoxic preconditioning). The possibility that a history of intermittent nocturnal hypoxia, such as occurs with simple obstructive sleep apnoea, might offer some protection against perioperative hypoxia-related morbidity warrants further examination.
In the meantime, we should stop losing sleep trying to identify all the patients with mild, moderate or even moderately severe OSA per se, and go back to using our individual judgement of patients to figure out their most appropriate perioperative management strategy. After all, we don't need a screening test to tell us that the bloke who weighs 130 kg and looks like a bulldog is going to be trouble if he needs lots of sedative analgesia. Similarly, we ought to understand that patients don't need to have any OSA at all to stop breathing if they get too much opioid.
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